AEGiS-WSJ: Clinton Foundation Donors Include Drug Makers: Jacob Goldstein reports on the Clinton foundation’s financial disclosure.

Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.

Clinton Foundation Donors Include Drug Makers: Jacob Goldstein reports on the Clinton foundationÆs financial disclosure.

Wall Street Journal Blog - December 18, 2008
Posted by Jacob Goldstein, washwire@wsj.com

Former President Bill ClintonÆs foundation picked up sizable contributions from AIDS drug makers and others in the pharmaceutical industry, according to the foundation financial records released today. The foundation released the records in advance of Hillary ClintonÆs nomination as secretary of state.

Drug industry contributors on the Clinton list include Pfizer Inc. (between $500,001 and $1 million) and Mylan Inc. ($100,001 to $250,000) of the U.S. and Ranbaxy Laboratories Ltd. ($100,001 to $250,000) of India. Pfizer and Ranbaxy both sell AIDS drugs, and Mylan owns a majority stake in Matrix Laboratories Ltd., an Indian drug maker that sells AIDS drugs.

Harold Snyder, who gave between $1,000,001 and $5 million, is a director of Israeli drug maker Teva Pharmaceutical Industries Ltd., according to the companyÆs Web site.

Through the PresidentÆs Emergency Plan for AIDS Relief, the U.S. purchases more than $400 million a year in AIDS drugs for patients in the developing world. The official in charge of PEPFAR serves under the secretary of state.

Many U.S. drug companies have big international operations and are affected by a myriad of intellectual property, trade, tax and safety issues in which the State Department can have involvement to one degree or another.

081218
WJ081205

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .